NoBleed_whatis
Related Topics :

NoBleedâ„¢

F.A.Q.

About Nosebleeds

Management of Nosebleeds

NoBleedâ„¢ References

NoBleedâ„¢ Testimonials

Study Results

NoBleed Preliminary Efficacy Study

Design: Pre-treatment and post-treatment questionnaire given to patients with a diagnosis of recurrent epistaxis. Length of treatment was two months. All patients applied NoBleed as directed in the product insert as the sole treatment of their epistaxis during this period.

Total Participants
24
Total 2nd response
18
Total study completion rate
68%
Percent of patient with epistaxis pre-treatment
79%
Average number of epistaxis events per month per patient pre-treatment
17
Average number of epistaxis events per month per patient post-treatment
4
Percent of patients with complete resolution epistaxis
61%
Percent of patients with partial resolution epistaxis
28%
Percent of patients with no decrease in epistaxis
11%
Percent of patients with decreased severity of epistaxis
94%
Percent of patients with decreased duration of epistaxis episodes
82%
Percent of patients tolerating treatment with NoBleed
94%
Percent of patients who would recommend this product 88%

 


 
about us | the founders | our story | our mission | our products | contact us
© 2007 gagephytolabs.com || design by SmartExpress